Page last updated: 2024-08-24

plerixafor and aspartic acid

plerixafor has been researched along with aspartic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridger, GJ; Gerlach, LO; Schwartz, TW; Skerlj, RT1
Bridger, G; De Clercq, E; Gerlach, LO; Hatse, S; Henson, G; Princen, K; Schols, D; Schwartz, TW1
Bridger, GJ; Gerlach, LO; Jakobsen, JS; Jensen, KP; Rosenkilde, MR; Ryde, U; Schwartz, TW; Skerlj, RT1

Other Studies

3 other study(ies) available for plerixafor and aspartic acid

ArticleYear
Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.
    The Journal of biological chemistry, 2001, Apr-27, Volume: 276, Issue:17

    Topics: Amino Acid Sequence; Animals; Anti-HIV Agents; Antiviral Agents; Asparagine; Aspartic Acid; Benzylamines; Binding, Competitive; Chemokine CXCL12; Chemokines, CXC; COS Cells; Cyclams; DNA, Complementary; Heterocyclic Compounds; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Linear Models; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Binding; Protein Conformation; Receptors, CXCR4; Transfection

2001
Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.
    Molecular pharmacology, 2001, Volume: 60, Issue:1

    Topics: Amino Acid Sequence; Anti-HIV Agents; Aspartic Acid; Benzylamines; Cyclams; Heterocyclic Compounds; HIV-1; Humans; Molecular Sequence Data; Mutation; Receptors, Chemokine; Receptors, CXCR4; Receptors, Virus; Transfection; Tumor Cells, Cultured

2001
Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor.
    Biochemistry, 2003, Jan-28, Volume: 42, Issue:3

    Topics: Amino Acid Sequence; Animals; Aspartic Acid; Benzylamines; Binding, Competitive; Carboxylic Acids; Cations, Divalent; Chemokine CXCL12; Chemokines, CXC; Copper; COS Cells; Cyclams; DNA Mutational Analysis; Heterocyclic Compounds; Humans; Ligands; Macromolecular Substances; Metals, Heavy; Molecular Sequence Data; Mutagenesis, Site-Directed; Nickel; Receptors, CXCR4; Transfection; Zinc

2003